944401-57-4

Basic information

• Product Name: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridin-2-amine
• Synonyms: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridin-2-amine;2-AMINO-4-(TRIFLUOROMETHYL) PYRIDINE-5-BORONIC ACID PINACOL ESTER;3-hydroxy-2,3-dimethylbutan-2-yl hydrogen (6-amino-4-(trifluoromethyl)pyridin-3-yl)boronate
• CAS NO: 944401-57-4
• Molecular Formula: C₁₂H₁₆BF₃N₂O₂
• Molecular Weight: 288.0738496
• Mol File: 944401-57-4.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 375.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.23
• Storage Temp.: 2-8°C(protect from light)
• PKA: 4.83±0.37(Predicted)
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridin-2-amine(944401-57-4)
• EPA Substance Registry System: 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridin-2-amine(944401-57-4)

Safety Data

• Hazardous Substances Data: 944401-57-4(Hazardous Substances Data)

Usage

Uses

2-Amino-4-(trifluoromethyl)pyridine-5-boronic acid pinacol ester is used as pharmaceutical intermediate.

InChI:InChI=1S/C12H16BF3N2O2/c1-10(2)11(3,4)20-13(19-10)8-6-18-9(17)5-7(8)12(14,15)16/h5-6H,1-4H3,(H2,17,18)

Upstream product

• 944401-56-3 2-amino-5-bromo-4-(trifluoromethyl)pyridine 
• 73183-34-3 bis(pinacol)diborane 

Relevant articles and documents

METHOD OF INHIBITING HAMARTOMA TUMOR CELLS

Dimorpholinopyrimidines are useful for inhibiting growth or proliferation of hamartoma tumor cells. Because the Dimorpholinopyrimidines inhibit the growth and proliferation of hamartoma tumor cells they are also useful in treating PTEN hamartoma tumor syndromes. The therapeutic and prophylactic treatments provided by this invention are practiced by administering to a patient in need thereof an amount of a compound of dimorpholinopyrimidine derivative that is effective to inhibit growth or proliferation of the hamartoma tumor cells.

PI 3-KINASE INHIBITORS AND METHODS OF THEIR USE

Phosphatidylinositol (PI) 3-kinase inhibitor compounds, their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases, including proliferative diseases, inflammatory and obstructive airways diseases, allergic conditions, auutoimmune and cardiovascular diseases.